Phase 2 Clinical Trials

BAY3283142 Phase 2 Results Expected

SHR-A1811 Injection Phase 2 Results Expected

Brenetafusp Phase 2 Results Expected

quaratusugene ozeplasmid Phase 2 Results Expected

LY3541860 Phase 2 Results Expected

Ratutrelvir (83-0060) non-randomised Phase 2 Results Expected

SHR-3167 Phase 2 Results Expected

Insulin Degludec Phase 2 Results Expected

HRS-8427 Phase 2 Results Expected

Pembrolizumab Phase 2 Results Expected

MIL62 Phase 2 Results Expected

LY3871801 Phase 2 Results Expected

ChAdOx1-HBV Phase 2 Results Expected

Meropenem Phase 2 Results Expected

Brexucabtagene Autoleucel (KTE-X19) Phase 2 Results Expected

ALTO-101 Phase 2 Results Expected

PA9159 Metered-Dose Inhaler, 60 μg per day for 28 days Phase 2 Results Expected

Sacituzumab Govitecan-hziy (SG) Phase 2 Results Expected

Fish Oil Phase 2 Results Expected

PBP1510 (400mg/16mL) Phase 2 Results Expected

Placebo Phase 2 Results Expected

MVA-HBV Phase 2 Results Expected

PG4 Phase 2 Results Expected

Candidate 1: PF-07915234: VZV modRNA Powder for Suspension for Injection Phase 2 Results Expected

Placebo Phase 2 Results Expected

mRNA-1345 Phase 2 Results Expected

TAK-360 Phase 2 Results Expected

Verekitug (UPB-101) Phase 2 Results Expected

doxecitine and doxribtimine Phase 2 Results Expected

AZD5462 Phase 2 Results Expected

tisotumab vedotin Phase 2 Results Expected

carboplatin Phase 2 Results Expected

cisplatin Phase 2 Results Expected

BIIB122 Phase 2 Results Expected

SAR443122 Phase 2 Results Expected

AZD3470 Phase 2 Results Expected

BGB-16673 Phase 2 Results Expected

Lu AG09222 Phase 2 Results Expected

Fezolinetant Phase 2 Results Expected

INS018_055 Phase 2 Results Expected

sotorasib Phase 2 Results Expected

ZL-1102 1% w/w gel BID for 16 weeks Phase 2 Results Expected

ARV-471 Phase 2 Results Expected

Abemaciclib Phase 2 Results Expected

SHR-A1904 Phase 2 Results Expected

SHR0302Base gel Phase 2 Results Expected

Dupilumab Phase 2 Results Expected

RSV/hMPV vaccine candidate Dose L Phase 2 Results Expected

VCA-894A Phase 2 Results Expected

MCLA-129 Phase 2 Results Expected

Remimazolam Tosilate for injection Phase 2 Results Expected

PA9159 Metered-Dose Inhaler, 120 μg per day for 28 days Phase 2 Results Expected

GS-1427 Phase 2 Results Expected

Tebapivat Phase 2 Results Expected

KYV-101 Phase 2 Results Expected

SA53-OS (phase 1) Phase 2 Results Expected

NVG-291 Phase 2 Results Expected

5-aminolevulinic acid Phase 2 Results Expected

Navepegritide Phase 2 Results Expected

Allocetra Phase 2 Results Expected

VIR-2218 Phase 2 Results Expected

HRS-9190 Phase 2 Results Expected

Daridorexant 25 mg Phase 2 Results Expected

NBI-921352 Phase 2 Results Expected

VIR-3434 Phase 2 Results Expected

BL-M07D1 Phase 2 Results Expected

BNT164a1 Phase 2 Results Expected

Standard lymphodepletion regimen Phase 2 Results Expected

AVTX-009 Regimen 1 Phase 2 Results Expected

Trichostatin A Phase 2 Results Expected

BT8009 Phase 2 Results Expected

Progerinin Phase 2 Results Expected

DS-3939a Phase 2 Results Expected

HZN-1116 Phase 2 Results Expected

Tiragolumab Phase 2 Results Expected

Tobemstomig Phase 2 Results Expected

REGN7544 Phase 2 Results Expected

Atezolizumab Phase 2 Results Expected

TAK-360 Phase 2 Results Expected

Lunsekimig Phase 2 Results Expected

GEN1047 is a bispecific antibody that induces T-cell mediated cytotoxicity of B7H4-positive tumor cells. Phase 2 Results Expected

LXH254 Phase 2 Results Expected

Belzutifan Phase 2 Results Expected

vilastobart (XTX101) Phase 2 Results Expected

IGC-AD1-Active Phase 2 Results Expected

SHR-3167 Phase 2 Results Expected

Insulin glargine Phase 2 Results Expected

Iptacopan (part 1) Phase 2 Results Expected

E7389-LF Phase 2 Results Expected

Fulvestrant Phase 2 Results Expected

E7090 Phase 2 Results Expected

AU-011 Phase 2 Results Expected

VI-0609 Phase 2 Results Expected

PF-07220060 CDK4 inhibitor Phase 2 Results Expected

Exemestane Phase 2 Results Expected

Pandemic flu H5 mRNA vaccine Phase 2 Results Expected

Dazostinag Phase 2 Results Expected

Redasemtide Phase 2 Results Expected

SAT-3247 Phase 2 Results Expected